Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus

The treatment of Type 2 Diabetes Mellitus (T2DM) consists primarily of oral antidiabetic drugs (OADs) that stimulate insulin secretion, such as sulfonylureas (SUs) and reduce hepatic glucose production (e.g., biguanides), among others. The marked inter-individual differences among T2DM patients’ res...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Ibarra, Hector E., Reyes-Cortes, Luisa M., Jiang, Xian-Li, Luna-Aguirre, Claudia M., Aguirre-Trevino, Dionicio, Morales-Alvarado, Ivan A., Leon-Cachon, Rafael B., Lavalle-Gonzalez, Fernando, Morcos, Faruck, Barrera-Saldaña, Hugo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898372/
https://www.ncbi.nlm.nih.gov/pubmed/29681852
http://dx.doi.org/10.3389/fphar.2018.00320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898372/
https://www.ncbi.nlm.nih.gov/pubmed/29681852
http://dx.doi.org/10.3389/fphar.2018.00320

Ejemplares similares